Use of DMARDs and corticosteroids at the start of infliximab treatment
| Therapy | Number (%) | |
|---|---|---|
| im, intramuscular; po, oral. | ||
| Drugs | ||
| Methotrexate | 63 (66%) | |
| Hydroxychloroquine | 16 (17%) | |
| Ciclosporine-A | 15 (16%) | |
| Leflunomide | 14 (15%) | |
| Podophyllotoxin | 12 (13%) | |
| Azathioprine | 12 (13%) | |
| Sulfasalazine | 11 (11%) | |
| Gold salts, im or po | 10 (10%) | |
| D-penicillamine | 1 (1%) | |
| Corticosteroids | 79 (82%) | |
| Strategy | ||
| No drugs | 0 | |
| Single therapy | 13 (14%) | |
| Single therapy with corticosteroids | 45 (47%) | |
| Corticosteroids alone | 0 | |
| Combination therapy | 4 (4%) | |
| Combination therapy with corticosteroids | 34 (35%) | |